1Bousquet J, D′Urzo A, Hebert J, et al.Comparison of the efficacy and safety of mometasone furoate dry powder inhaler to budesonide Turbuhaler.Eur Respir J,2000,16:808-816.
2O′Connor B, Bonnaud G, Haahtela T, et al.Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.Ann Allergy Asthma Immunol,2001,86:397-404.
3Kemp JP, Berkowitz RB, Miller SD, et al.Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma.J Allergy Clin Immunol,2000,106:485-492.
4Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group.N Engl J Med, 2000,343:1054-1063.
5Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma.N Engl J Med, 2000,343:1064-1069.
6Mcivor RA, Pizzichini E, Turner MO, et al.Potential masking effects of salmeterol on airway inflammation in asthma.Am J Respir Crit Care Med, 1998,158:924-930.
7Kips JC, O′Connor BJ, Inman MD, et al.A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.Am J Respir Crit Care Med,2000,161(3 Pt 1):996-1001.
8Jenkins C, Woolcock AJ, Saarelainen P, et al.Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma.Respir Med,2000,94:715-723.
9Evans DJ, Taylor DA, Zetterstrom O, et al.A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.N Engl J Med,1997,337:1412-1418.
10Storms W, Michele TM, Knorr B,et al.Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged > or = 6 years.Clin Exp Allergy,2001,31:77-87.
